Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FLGT - Fulgent Genetics Inc


IEX Last Trade
22.61
-0.510   -2.256%

Share volume: 135,019
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$23.12
-0.51
-2.21%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-5.21%
1 Month
-5.80%
3 Months
5.67%
6 Months
-3.61%
1 Year
-32.80%
2 Year
-48.90%
Key data
Stock price
$22.61
P/E Ratio 
-4.18
DAY RANGE
N/A - N/A
EPS 
-$5.46
52 WEEK RANGE
$18.91 - $32.49
52 WEEK CHANGE
-$0.31
MARKET CAP 
683.493 M
YIELD 
N/A
SHARES OUTSTANDING 
30.297 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/01/2024
BETA 
0.85
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$105,100
AVERAGE 30 VOLUME 
$159,802
Company detail
CEO: Ming Hsieh
Region: US
Website: https://www.fulgentgenetics.com/
Employees: 428
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques

Recent news